In-depth analysis of circulating and tumor-resident B cells in metastatic cutaneous melanoma reveals abnormalities in B cell profiles and antibody recombination, with IgA1 playing a role in promoting tumor progression (87). The gene discussed is IGHA1; the disease is neoplasm.